跳至主要内容
临床试验/NCT06596798
NCT06596798进行中(未招募)不适用

Research on the Risk Warning Model and Prevention Strategies for Acute Kidney Injury Associated With Tacrolimus Based on Explainable Deep Neural Networks and Therapeutic Drug Monitoring

Qianfoshan Hospital1 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2024年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
1,200
试验地点
1
主要终点
AKI

研究概览

简要总结

In this study, the investigators aim to develop a risk prediction model for acute kidney injury (AKI) in hospitalized patients using the calcineurin inhibitor tacrolimus. This will be achieved by mining electronic medical record data and employing explainable deep learning methods. The model will provide clinical decision support for timely intervention and treatment. Compared to traditional machine learning models, deep neural networks can extract more nuanced features from complex medical data and perform more precise pattern recognition, thereby enhancing prediction accuracy and reliability. By constructing a predictive tool based on explainable deep learning models, the investigators will better assess the association between the use of calcineurin inhibitors and AKI, explore targeted prevention strategies, and offer more precise predictions and intervention guidance to clinicians. Additionally, this research has significant socio-economic benefits and application potential. By reducing the incidence of AKI, the investigators can lower patient hospitalization duration and re-treatment costs, conserve medical resources, and improve patient quality of life. Preventive healthcare not only alleviates the physical and psychological burden on patients but also reduces the strain on the healthcare system, enhances healthcare efficiency, and promotes the rational allocation of medical resources.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Use of tacrolimus during hospitalization, with standardized therapeutic drug monitoring
  • Age of 18 years or older at the time of admission
  • Length of hospital stay ≥ hours
  • At least two serum creatinine level tests conducted during the hospital stay

排除标准

  • Stage 5 chronic kidney disease prior to admission
  • Incomplete clinical data
  • Serum creatinine levels consistently below 40 mmol/L during hospitalization

结局指标

主要结局

AKI

时间窗: From January 2020 to December 2023

Acute kidney injury occurred after the patient took tacrolimus during hospitalization

次要结局

未报告次要终点

研究者

发起方
Qianfoshan Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiao Li,MD

Associate professor of pharmacy

Qianfoshan Hospital

研究点 (1)

Loading locations...

相似试验